Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Taiwan Equity Fund · Direct ✕HDFC Pharma and Healthcare Fund · Direct ✕

Growth of ₹10,000

Basics

Nippon India Taiwan Equity FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseNippon IndiaHDFC
NAV₹21.5146₹23.6750
NAV date20 Nov 202620 Nov 2026
History4.9 years3.1 years
Expense ratio1.2%1.1%
Stars★★★★★★★★★★
Growth Score63.0094.50

Returns

Nippon India Taiwan Equity FundHDFC Pharma and Healthcare Fund
1 month−38.42%+12.97%
3 months−40.87%+7.13%
6 months−39.22%+17.84%
YTD+12.60%+33.73%
1 year+22.14%+32.20%
3 years (CAGR)+31.07%+30.70%
5 years (CAGR)——
10 years (CAGR)——
Since launch+17.37%+31.83%

Risk

Nippon India Taiwan Equity FundHDFC Pharma and Healthcare Fund
Volatility42.4%15.8%
Downside volatility26.9%8.5%
Sharpe0.581.53
Sortino0.912.86
Calmar0.662.06
Return / risk0.731.95
Deepest fall−47.10%−14.91%
Days to recover—126
Below its high−47.10%+0.00%

Against benchmark

Nippon India Taiwan Equity FundHDFC Pharma and Healthcare Fund
Alpha+30.87%+7.54%
Beta−0.140.97
R²0.3%85.0%
Up capture63.8%108.9%
Down capture−69.8%71.0%
Tracking error46.1%6.1%
Information ratio0.541.17
Treynor−1.830.24

Consistency

Nippon India Taiwan Equity FundHDFC Pharma and Healthcare Fund
Best 1-year+279.48%+67.01%
Middle 1-year+35.02%+23.25%
Worst 1-year−33.56%+1.71%
1-year periods with a loss13.9%0.0%
Middle 3-year+39.17%+30.22%
Positive months66.7%72.2%
Best day+16.58%+3.18%
Worst day−8.88%−3.61%
Worst 5% day−3.89%−1.51%
Positive days56.7%58.3%
NAVs a year233247

SIP of ₹10,000 a month

Nippon India Taiwan Equity FundHDFC Pharma and Healthcare Fund
5-year XIRR——
5-year value——
3-year XIRR+27.98%+27.71%
1-year XIRR−30.88%+41.37%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth